主要文件

查看所有文档

B0149

酸性蓝83

Name: 酸性蓝83
Brand: SIAL

Dye content ~50 %, Powder

别名:

Coomassie 亮蓝R, 亮吲哚蓝蛋白 6B, 酸性蓝 83

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:

C₄₅H₄₄N₃NaO₇S₂

化学文摘社编号:

6104-59-2

分子量:

825.97

UNSPSC Code:

12171500

NACRES:

NA.47

PubChem Substance ID:

24891505

EC Number:

228-060-5

MDL number:

MFCD00041762

Beilstein/REAXYS Number:

5718025

Colour Index Number:

42660

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

产品名称

酸性蓝83, Dye content ~50 %, Technical grade

Quality Level

200

form

powder

composition

Dye content, ~50%

technique(s)

microbe id | staining: suitable

solubility

H₂O: 10 mg/mL

suitability

suitable for detection of protein bands following electrophoresis.

application(s)

diagnostic assay manufacturing
hematology
histology

storage temp.

room temp

SMILES string

[Na+].CCOc1ccc(Nc2ccc(cc2)C(\c3ccc(cc3)N(CC)Cc4cccc(c4)S([O-])(=O)=O)=C5\C=C/C(C=C5)=[N+](\CC)Cc6cccc(c6)S([O-])(=O)=O)cc1

InChI

1S/C45H45N3O7S2.Na/c1-4-47(31-33-9-7-11-43(29-33)56(49,50)51)40-23-15-36(16-24-40)45(35-13-19-38(20-14-35)46-39-21-27-42(28-22-39)55-6-3)37-17-25-41(26-18-37)48(5-2)32-34-10-8-12-44(30-34)57(52,53)54;/h7-30H,4-6,31-32H2,1-3H3,(H2,49,50,51,52,53,54);/q;+1/p-1

InChI key

NKLPQNGYXWVELD-UHFFFAOYSA-M

正在寻找类似产品? 访问产品对比指南

General description

亮蓝R（C.l.42660）是一种三氨基三芳基甲烷染料，其中两个氨基被苄基化，一个氨基被苯基化。它也被称为亮吲哚菁6B和考马斯蓝R250。

Application

亮蓝R已广泛用于十二烷基硫酸钠-聚丙烯酰胺凝胶电泳（SDS-PAGE）后的蛋白条带检测。其他应用包括：

用作环氧树脂包埋组织切片蛋白染色剂
定量显微密度测定切片内的蛋白质
染色单体、肌动蛋白微丝，神经突和精子顶体显影。

电泳后检测蛋白条带。

Legal Information

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Role of matrix metalloproteinase-2 in the cardioprotective effect of ischaemic postconditioning.

Donato M, et al.

Experimental Physiology, 95, 274-281 (2010)

Effect of Flammulina velutipes on spent-hen breast meat tenderization.

Kang GH, et al.

Poultry Science, 91, 232-236 (2012)

The strategic combination of trastuzumab emtansine with oncolytic rhabdoviruses leads to therapeutic synergy.

Rozanne Arulanandam et al.

Communications biology, 3(1), 254-254 (2020-05-24)

We have demonstrated that microtubule destabilizing agents (MDAs) can sensitize tumors to oncolytic vesicular stomatitis virus (VSVΔ51) in various preclinical models of cancer. The clinically approved T-DM1 (Kadcyla®) is an antibody-drug conjugate consisting of HER2-targeting trastuzumab linked to the potent

Transcription-terminating mutation in telethonin causing autosomal recessive muscular dystrophy type 2G in a European patient.

Montse Olivé et al.

Neuromuscular disorders : NMD, 18(12), 929-933 (2008-10-25)

A 27-year-old woman of Moldavian origin presented at the age of 15 with progressive proximal limb weakness and painful cramps in her calf muscles. Clinical examination revealed prominent muscle weakness in proximal muscles of the lower extremities and distal anterior

Peptide mass fingerprint sequence coverage from differently stained proteins on two-dimensional electrophoresis patterns by matrix assisted laser desorption/ionization-mass spectrometry (MALDI-MS).

C Scheler et al.

Electrophoresis, 19(6), 918-927 (1998-06-25)

Identification of proteins separated by two-dimensional electrophoresis (2-DE) is a necessary task to overcome the purely descriptive character of 2-DE and a prerequisite to the construction of 2-DE databases in proteome projects. Matrix assisted laser desorption/ionization-mass spectrometry (MALDI-MS) has a

查看所有相关文献

全球贸易项目编号

货号	GTIN
B0149-25G	04061833419519
B0149-5G	04061833419526
B0149-100G	04061833419502
B0149-500G	04061832340043

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持